Statin treatment may lower the risk of postradiation epilepsy in patients with nasopharyngeal carcinoma

Epilepsia. 2017 Dec;58(12):2172-2177. doi: 10.1111/epi.13924. Epub 2017 Oct 16.

Abstract

Objective: This study aimed to clarify the effect of statins on preventing the risk of postradiation epilepsy.

Methods: We performed a retrospective analysis of neurological nasopharyngeal carcinoma patients with a history of radiotherapy. Patients with a history of epilepsy before radiation and those who received prophylactically antiepileptic treatment were excluded. The demographic and clinical data of these patients were collected through chart review. We used Kaplan-Meier analysis (log-rank test) to examine the effect of statins on epilepsy-free survival. Cox regression analysis was utilized to identify independent predictive variables.

Results: Our study included 532 patients (405 males and 127 females) with a mean follow-up of 28.1 months. During follow-up, 471 (88.5%) patients developed radiation-induced brain necrosis (RN). Within a mean latency of 24.1 months, 88 (16.5%) patients experienced epilepsy, of whom 27 (27 of 88, 30.7%) patients suffered from epilepsy before the diagnosis of RN. Thirty-six (36 of 88, 40.9%) cases of epilepsy occurred after RN onset, and in 22 cases (22 of 88, 25.0%) epilepsy was the first presentation of RN. Three patients suffered from epilepsy but did not have RN. Eighty-eight patients in our cohort were treated with statins because of hyperlipidemia or prevention of cardiocerebrovascular diseases, of whom six (6.8%) developed epilepsy, whereas in those without statin, the epileptic rate was 18.5%. Log-rank test found that there was a significant difference in epilepsy-free survival between patients who used statins and those who did not (p = 0.016). After adjusting for confounding variables, multivariate Cox regression analysis revealed that statin use could still significantly reduce the risk of epilepsy after radiation (hazard ratio = 0.36, 95% confidence interval = 0.15-0.82, p = 0.015). However, for the patients who already suffered from RN, statin treatment did not lower the risk of post-RN epilepsy.

Significance: Early statin use may reduce the risk of postradiotherapy epilepsy in patients with nasopharyngeal carcinoma.

Keywords: Epilepsy; Radiation; Statin.

MeSH terms

  • Adult
  • Aged
  • Carcinoma / complications*
  • Carcinoma / radiotherapy*
  • Disease-Free Survival
  • Epilepsy / epidemiology
  • Epilepsy / etiology*
  • Epilepsy / prevention & control*
  • Female
  • Follow-Up Studies
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
  • Kaplan-Meier Estimate
  • Male
  • Middle Aged
  • Nasopharyngeal Carcinoma
  • Nasopharyngeal Neoplasms / complications*
  • Nasopharyngeal Neoplasms / radiotherapy*
  • Radiotherapy / adverse effects*
  • Retrospective Studies
  • Risk Factors
  • Survival Analysis

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors